Bringing the fundamentals into focus…
Back to Keros Therapeutics, Inc.
How Keros Therapeutics, Inc. stacks up
KROS · against 557 other Healthcare companies listed in US-listed
Profitability
5/ 100
Near the bottom of its peers.
Ranked #498 of 558 · scores higher than 9% of peers
Bars: peers in each 10-point band of the profitability score100 peers with a profitability score of 0–9, including KROS · Click a bar to see the companies
Why profitability scores 5?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on invested capital, operating margin and return on assets, which are weaker than most Healthcare peers.
- a lower return on invested capital: weaker than 99% of peers. Return on invested capital: -1700.5% vs peer median 4.7%
- a thinner operating margin: weaker than 94% of peers. Operating margin: -675.8% vs peer median 7.1%
- a lower return on assets: weaker than 85% of peers. Return on assets: -28.9% vs peer median 1.7%
Metric by metric
Position: dot = KROS, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | KROS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 517 reported | -1700.5% | -7.0% | 2% | 33% | |
| Operating marginHigher is better · 479 reported | -675.8% | -2.4% | 12% | 33% | |
| Return on assetsHigher is better · 582 reported | -28.9% | -7.8% | 29% | 33% | |
| Return on equityHigher is better · 531 reported | -17.2% | -19.7% | 52% | Context only | |
| Gross marginHigher is better · 601 reported | 0.0% | 43.9% | 6% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around KROS| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 595M USD | 99 | 97 | |
| 1 | 433M USD | 99 | 81 | |
| 1 | 17.9B USD | 99 | 76 | |
| 1 | 52.9B USD | 99 | 57 | |
| 1 | 578M USD | 99 | 73 | |
| 498 | 5.7B USD | 5 | 52 | |
| 498 | 4.8B USD | 5 | 27 | |
| 498 | 4.6B USD | 5 | 29 | |
| 498 | 327M USD | 5 | 11 | |
| 498 | 215M USD | 5 | 34 | |
| 498 | 1.7B USD | 5 | 33 | |
| 498 | 12M USD | 5 | 38 | |
| 498 | 469M USD | 5 | 45 | |
| 498 | 549M USD | 5 | 30 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score